Navigation Links
Celator(R) Pharmaceuticals Presents New Data on CPX-351 And CPX-1 at the American Association for Cancer Research
Date:4/22/2009

PRINCETON, N.J., April 22 /PRNewswire/ -- Celator Pharmaceuticals today announced that new data from animal studies of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in consolidation treatment for leukemia and of CPX-1 (Irinotecan HCl:Floxuridine) Liposome Injection in combination with biological agents for the treatment of colorectal cancer were presented at the 100th Annual Meeting of the American Association for Cancer Research (AACR) in Denver, Colorado (Abstracts 4568 and 4578).

"Even as we progress through Phase 2 human clinical trials with both CPX-351 and CPX-1, our ongoing work in xenograft models of human cancer provides important additional direction regarding their potential place in current treatment paradigms," said Scott Jackson, chief executive officer, Celator Pharmaceuticals. "These studies, which further highlight the utility of maintaining synergistic molar ratios of chemotherapeutic agents through nano-scale delivery vehicles, also suggest strategies for enhancing clinical outcomes with CPX-351 in leukemia and CPX-1 in colorectal cancer."

In the first presentation, researchers reported that CPX-351 was superior to standard cytarabine:daunorubicin free-drug cocktail in ablating leukemic bone marrow cells in the CCRF-CEM human leukemia xenograft model. Additional data showed median survival was improved by consolidation treatment with either CPX-351 or free drug cocktail therapies but long-term survival (beyond 100 days) was achieved only with CPX-351 induction and consolidation therapy. Furthermore, it appeared that intermediate dosing frequencies (days 1 & 3 or days 1 & 5) for consolidation treatment with CPX-351 produced superior efficacy to a longer dosing frequency (days 1 & 7), with regard to both survival improvement and bone marrow drug accumulation. Recovery times of normal bone marrow cellularity following consolidation treatments were comparable among all three conso
'/>"/>

SOURCE Celator Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Frederick R. Appelbaum, M.D. and Ross C. Donehower, M.D. Join Scientific Advisory Board of Celator(R) Pharmaceuticals
2. Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting
3. Celator(R) Pharmaceuticals To Present at Biotech Showcase 2009
4. Celator(R) Pharmaceuticals Enrolls First Patient in Its Phase 2 Study of CPX-351 in Acute Myeloid Leukemia in First Relapse
5. Celator(R) Pharmaceuticals to Present at Future Leaders in the Biotech Industry Conference
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
11. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... HealthDay Reporter MONDAY, ... appear to have a slightly increased risk of potentially ... Swedish researchers report. Doctors have previously suspected that ... raised risk of deep vein thrombosis and pulmonary embolism, ... veins, the researchers noted in background information. This ...
(Date:7/28/2014)... 28, 2014 The Oneida Indian Nation ... incredible field of accompanying PGA TOUR players will be ... analyst Notah Begay III for the seventh annual Notah ... Stone Resort Casino ’s Atunyote® Golf Club on Wednesday, ... Woods, Jason Dufner, Jimmy Walker, Jonas Blixt, Angel Cabrera ...
(Date:7/28/2014)... mobile devices are on the cusp of revolutionizing health ... providing everything from cardiac measurements to sonograms. , While ... and control costs, several health law experts say in ... (NEJM) report that more oversight is needed by the ... confidence and safety. Out of some 100,000 mHealth apps ...
(Date:7/28/2014)... New York (PRWEB) July 28, 2014 ... edition of “Organic Living” on March 12th, a campaign ... an organic lifestyle. In partnership with industry leader ... over 100 Certified Organic teas, the campaign provides readers ... recent years that continues to propel the industry forward ...
(Date:7/28/2014)... July 28, 2014 Irresistible infants have met their ... of Comfort. The online gifting company specializes in homemade chicken noodle ... The New Baby package starts with home-from-the-hospital essentials every new parent ... 6 rolls , 6 cookies , ... The soup is ready to heat and eat upon delivery, so ...
Breaking Medicine News(10 mins):Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 2Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 3Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 2Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 3Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 4Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 5Health News:Booming mobile health app market needs more FDA oversight for consumer safety, confidence 2Health News:Mediaplanet's "Organic Living" Campaign Raises Awareness About What Nature Invented, With the Help of Partner TEALUX 2Health News:Spoonful of Comfort Announces "New Baby" Gift Package 2
... oncologist and Craig Greven, Vitreoretinal surgeon, Wake Forest University ... with radiation therapy. Uveal malignant melanoma// is a rare ... people per year in the United States. It is ... seen in nonwhite races. The results of the study ...
... was first initiated in India to help overcome Vitamin ... in India, it now lags behind African and neighbouring ... report.,The report entitled "Controlling Vitamin and Mineral Deficiencies in ... the largest percentage as well as the largest absolute ...
... Alzheimer’s disease (AD), characterized by progressive memory loss, decline ... a major threat to ageing population.// ,A ... reviews the different strategies in drug discovery. Hong-Yu Zhang, ... of the present one-drug-one-target strategy in drug discovery is ...
... levels of low density lipoprotein (LDL) (also called bad ... are taking statins.// ,Those taking high doses of ... milligrams/deciliters to as low as 40 mg/dL. No one ... P. Cannon, a cardiologist at Brigham and Women's Hospital ...
... to a diverse range of insults, such as surgery, ... range of cell types of the immune system, creating ... inflammatory response, although essential for fighting infection, may damage ... mediators, cytokines and lipid mediators being the key mediators. ...
... Singh and Union Health Minister Anbumani Ramadoss are to convene ... problem of bird flu epidemic. //Awareness of bird flu and ... to the Western countries. The World Health Organization has sent ... if there are any possible flu attack. Dr. Anbumani said ...
Cached Medicine News:Health News:Radiation therapy effective against Eye cancer 2Health News:Vitamin A supplementation inadequate in India: Need for effective strategies 2Health News:The ideal composition of intravenous lipid emulsion 2
(Date:7/28/2014)... , July 28, 2014  Array BioPharma ... results for the fourth quarter and full ... conference call to discuss those results on ... Executive Officer and Michael Carruthers , ... Call InformationDate:Tuesday, August 12, 2014Time:9:00 a.m. Eastern ...
(Date:7/28/2014)... 28, 2014  A prospective study conducted by ... has validated the performance of VolparaDensity breast ... associated volumetrically assessed breast density measurements to breast ... & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), the article, "Automated ... widespread breast cancer risk assessment," was authored by ...
(Date:7/28/2014)... -- Houston dentist , Dr. Behzad Nazari ... Invisalign. With access to this increasingly popular orthodontic ... without feeling self-conscious in the process. Invisalign offers ... of braces, but patients who choose Invisalign over ... support for their oral health and comfort during ...
Breaking Medicine Technology:Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4Houston Cosmetic Dentist, Dr. Behzad Nazari, Now Offers Orthodontic Treatment with Invisalign 2
... a good night,s sleep to overall health have long been ... gender and weight management play in overall sleep patterns.  The ... Sleep and BMI , was presented during a poster session ... week. (Photo: http://photos.prnewswire.com/prnh/20111004/NE78562 ) ...
... YORK, Oct. 4, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0177915/US-Market-for-Neurological-Devices-2010.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment In 2009, ... valued at just over $2.2 billion, an ...
Cached Medicine Technology:Research Presented at The Obesity Society Meeting Shows Link Between BMI and Sleep Patterns 2Research Presented at The Obesity Society Meeting Shows Link Between BMI and Sleep Patterns 3U.S. Market for Neurological Devices 2010 2U.S. Market for Neurological Devices 2010 3U.S. Market for Neurological Devices 2010 4U.S. Market for Neurological Devices 2010 5U.S. Market for Neurological Devices 2010 6U.S. Market for Neurological Devices 2010 7U.S. Market for Neurological Devices 2010 8U.S. Market for Neurological Devices 2010 9U.S. Market for Neurological Devices 2010 10U.S. Market for Neurological Devices 2010 11U.S. Market for Neurological Devices 2010 12U.S. Market for Neurological Devices 2010 13U.S. Market for Neurological Devices 2010 14U.S. Market for Neurological Devices 2010 15U.S. Market for Neurological Devices 2010 16U.S. Market for Neurological Devices 2010 17
Triad Plus PVP-I Scrub Winged Sponges...
Prevail is a fast-acting, effective antimicrobial gel that makes preoperative preps easier. This unique gel formulation comes in a specifically designed, easy to use applicator for excellent flow con...
The applicator is designed for a smooth delivery of the solution for surgical procedures....
... Performance Panel consists of plasma specimens with ... for antibodies to the Hepatitis C Virus. ... manufacturers and diagnostic laboratories to evaluate their ... test systems are included for comparative analysis ...
Medicine Products: